Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Accelerated Partial Breast Radiotherapy With Either a Novel Breast Brachytherapy Technique - Mammosite or Intensity Modulated Radiotherapy

NCT01185145 is registered in ClinicalTrials.gov with Rocky Mountain Cancer Centers as lead sponsor.

NCT NCT01185145
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01185145 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Accelerated Partial Breast Radiotherapy With Either a Novel Breast Brachytherapy Technique - Mammosite or Intensity Modulated Radiotherapy
Lead sponsor
Rocky Mountain Cancer Centers
Phase
Phase 2
Overall status
Unknown status
Start date
February 29, 2004
Completion date
August 31, 2024
Enrollment
291 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer